Julie Zhen Qin Wu

Array ( [id] => 10057531 [patent_doc_number] => 09096877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use' [patent_app_type] => utility [patent_app_number] => 13/499007 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 95 [patent_no_of_words] => 102540 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359582 [patent_doc_number] => 20120214744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'POLYPEPTIDES AND NUCLEIC ACIDS FOR TREATING ERBB2-DEPENDENT CANCERS' [patent_app_type] => utility [patent_app_number] => 13/497924 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12610 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5991276 [patent_doc_number] => 20110099647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA' [patent_app_type] => utility [patent_app_number] => 12/886930 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 94742 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20110099647.pdf [firstpage_image] =>[orig_patent_app_number] => 12886930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416661 [patent_doc_number] => 20120244161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'DOSAGE REGIMEN FOR ADMINISTERING AN EpCAMxCD3 BISPECIFIC ANTIBODY' [patent_app_type] => utility [patent_app_number] => 13/496836 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15724 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476593 [patent_doc_number] => 20120276000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'CLEC14A INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/393921 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22210 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482852 [patent_doc_number] => 20120282259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'MUTANT SMOOTHENED AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/394069 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 48456 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9983128 [patent_doc_number] => 09028831 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Markers for selecting personalized therapies for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/393215 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11098 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8240296 [patent_doc_number] => 20120149031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'ANTI-CMET ANTIBODY AND ITS USE FOR THE DETECTION AND THE DIAGNOSIS OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/391435 [patent_app_country] => US [patent_app_date] => 2010-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20003 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359016 [patent_doc_number] => 20120214174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'GENE AND POLYPEPTIDE RELATING TO BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/392058 [patent_app_country] => US [patent_app_date] => 2010-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21371 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600623 [patent_doc_number] => 20100292312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'ANTI-DLL4 ANTIBODIES AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 12/848944 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 49214 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292312.pdf [firstpage_image] =>[orig_patent_app_number] => 12848944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952405 [patent_doc_number] => 20110033471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING TUMOR CELL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/846440 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 6917 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033471.pdf [firstpage_image] =>[orig_patent_app_number] => 12846440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8920475 [patent_doc_number] => 08486406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections' [patent_app_type] => utility [patent_app_number] => 13/265542 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4015 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601373 [patent_doc_number] => 20100322935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Tri- or Tetraspecific Antibodies' [patent_app_type] => utility [patent_app_number] => 12/788967 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16520 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322935.pdf [firstpage_image] =>[orig_patent_app_number] => 12788967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138523 [patent_doc_number] => 20120093814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'Fusion Proteins Comprising Canine FC Portions' [patent_app_type] => utility [patent_app_number] => 13/254887 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16509 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093814.pdf [firstpage_image] =>[orig_patent_app_number] => 13254887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8240297 [patent_doc_number] => 20120149022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSIS AND PROGNOSIS OF COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/148881 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9064 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158461 [patent_doc_number] => 20120100140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'STABILIZED FC POLYPEPTIDES WITH REDUCED EFFECTOR FUNCTION AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/145994 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 70910 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100140.pdf [firstpage_image] =>[orig_patent_app_number] => 13145994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048448 [patent_doc_number] => 20110207667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'EFFICIENT EXPRESSION OF TRUNCATED HUMAN RNASET2 IN E. COLI' [patent_app_type] => utility [patent_app_number] => 13/126494 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16736 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207667.pdf [firstpage_image] =>[orig_patent_app_number] => 13126494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8441482 [patent_doc_number] => 20120258099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'INHIBITORS OF GUANINE EXCHANGE FACTORS AND THEIR USE AS ANTICANCER DRUGS' [patent_app_type] => utility [patent_app_number] => 13/503092 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16980 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488517 [patent_doc_number] => 20110236894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/120861 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 61335 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236894.pdf [firstpage_image] =>[orig_patent_app_number] => 13120861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818760 [patent_doc_number] => 20120065380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'DUAL TARGETING ANTIBODY OF NOVEL FORM, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/319899 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11786 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065380.pdf [firstpage_image] =>[orig_patent_app_number] => 13319899 [rel_patent_id] =>[rel_patent_doc_number] =>)